Cadonilimab (Anti-PD-1 & CTLA-4)
Catalogue Number: A4002-SEL
| Manufacturer: | Selleck Chemicals |
| Type: | Recombinant Monoclonal |
| Alias: | AK104 |
| Shipping Condition: | Dry Ice |
| Storage Condition: | -70°C |
| Unit(s): | 1 mg |
Additional Text
Storage Note
-80°C
Short Description
Cadonilimab is a humanized tetravalent bispecific IgG1 antibody targeting human PD-1 and CTLA-4 with potential immune checkpoint inhibitory and antineoplastic activities. It has the potential to treat recurrent or metastatic cervical cancer. MW : 198.64 KD.
A4002 MSDS
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations